index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Epigenetics Muscles/physiopathology Becker muscular dystrophy BMD Molecular Sequence Data Duchenne muscular dystrophy CTNNB1 Diseases Activin Receptors Gene Expression Regulation/drug effects Becker muscular dystrophy Génomique Duchenne DMD dystrophy Dystrophie Musculaire de Duchenne DMD Human Umbilical Vein Endothelial Cells Long QT Dynamin 2 Dystrophin-EGFP LncRNA Animal/physiopathology Dystrophin central domain LncARN DMO Inbred C57BL Cardiomyopathie Delivery DHPR α1S Animals Cardiomyopathy Energy Metabolism/drug effects Mice Multi resolution modeling Immunoglobulin Fc Fragments/pharmacology Humans Mdx mouse Dystrophie Musculaire de Becker BMD LKB1 L-Type NNOS Invivo Autophagy Modificateurs de gènes Dystrophin Molecular docking Inhibitors Metabolism Genomic Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Dystrophie musculaire de Becker Homeostasis Base Sequence Male Long noncoding RNA Cell Biology Mitochondrial fission Becker BMD muscular dystrophy Calcium Channels Clinical trials Liver Muscle Strength Myotendinous junction Myogenesis Inbred mdx Morphogenesis Hear Cell homeostasis Muscular Atrophy MES Duchenne muscular dystrophy DMD Skeletal muscle Calcium Multi exon skipping BMD Cultured Muscular dystrophy Drp1 NAD+ Muscle development Cells CaV subunits Muscle Multiresolution modeling Cell Line Cachexia CaVβs Dystrophine DMD Ex-vivo Muscle Biology Knockout Muscular Dystrophy MiARN Antisense oligonucleotides Exon skipping Gene expression Gene modifiers Allele‐specific silencing therapy Dystrophy Hepatocellular carcinoma CD38 Centronuclear myopathy